Recent Peptide Publications


Global Peptide Groups

Featuring Internationally Notable Peptide Science Research Groups.

The Chmielewski Group

Jean Chmielewski · Purdue University

The Chmielewski Group at Purdue University, led by Alice Watson Kramer Distinguished Professor of Chemistry Jean Chmielewski, designs peptides to do work where small molecules struggle: enter macrophages to kill intracellular pathogens, assemble into ordered biomaterials through metal-ligand chemistry, deliver folded protein cargo across cell membranes, and reach HIV reservoirs …

Read More

Peptide Postdocs

Recognizing postdoctoral researchers advancing peptide science.

Saan Voss

UKRI Knowledge Transfer Partner at the University of Cambridge and Bicycle Therapeutics
David Spring Lab, Cambridge University

From a childhood cold that sparked a lifelong fascination with molecular equilibria to a pandemic-disrupted Ph.D. conducted across a ten-hour time difference, Saan Voss has built his career by adapting to new environments. Now a UKRI Knowledge Transfer Partner at the University of Cambridge and Bicycle Therapeutics, he develops diagnostics …

Read More

Peptide Pioneers

Celebrating new faculty launching independent peptide research.

Andrew Brennan

Assistant Professor
Brennan Lab, University of Bath

Andy Brennan's path through peptide science reads like a tour of the UK's leading protein chemistry groups, each stop adding new tools to his repertoire. His introduction to peptides began during his undergraduate studies at the University of Bristol in the laboratory of Dek Woolfson, where he explored coiled-coil helical …

Read More

Student Spotlight

Highlighting outstanding graduate students shaping the future of peptide science.

Arunima Sandeep

4th-Year Ph.D. Candidate
The Isabelle Marcotte Lab, Université du Québec à Montréal

Arunima Sandeep is a fourth-year Ph.D. candidate in the Marcotte Lab at the Université du Québec à Montréal, where she uses solid-state NMR to map how antimicrobial peptides engage the bacterial cell envelope. Her recent first-author paper in J. Am. Chem. Soc. established wall teichoic acids as direct molecular targets in Gram-positive bacteria, and she …

Read More

Peptide Primers

Educational resources for peptide science.

Peptide Synthesis for Beginners

A practical guide to manual Fmoc solid-phase peptide synthesis for researchers new to the technique. Covers equipment setup, the coupling and cleavage cycle, purification by preparative HPLC, and analytical characterization by CD, NMR, and X-ray crystallography. Includes troubleshooting, common mistakes, and tips for difficult sequences.

Start Learning

Peptide News

The latest from the peptide science community.

2027 du Vigneaud Call for Nominations

May 8, 2026

Read more

Helma Wennemers Receives the Wilhelm Ostwald Medal

Prof. Helma Wennemers is one of two recipients this year of the Wilhelm Ostwald Medal, the Saxon Academy of Sciences' most important prize, awarded in a ceremony at Leipzig's Old Town Hall. The Academy recognized Wennemers for her work on bio-inspired catalysts and functional peptide systems, which has expanded the interface between organic and biological chemistry and established peptide-based catalysis as a distinct field. The medal, named for the 1909 Nobel laureate in chemistry, has been awarded since 1978 for achievement in the natural sciences and engineering.

May 7, 2026

Read More

Svetlana Mojsov Awarded 2026 King Faisal Prize
APS member Svetlana Mojsov, a biochemist at The Rockefeller University, has received the 2026 King Faisal Prize in Medicine for the foundational chemistry that made today's GLP-1 therapies possible. Her work in the 1970s and 1980s at Rockefeller and Massachusetts General Hospital identified the biologically active form of glucagon-like peptide-1 and laid the groundwork for blockbuster metabolic medicines including Ozempic, Wegovy, and Rybelsus. Presented in Riyadh on April 15, the prize joins a recent cascade of honors recognizing her long-overdue place in the GLP-1 story.

Apr 24, 2026

Read More

GLP-1 Medicines Expand Into New Disease Territory
APS member Richard DiMarchi, Distinguished Professor at Indiana University and pioneer of GLP-1 multiagonist chemistry, is prominently featured in a major New York Times opinion essay on the expanding therapeutic frontier of GLP-1 medicines. The piece explores how a drug class originally developed for diabetes is now being used, and studied, for conditions ranging from traumatic brain injury to addiction to autoimmune disease.

Apr 16, 2026

Read More